Employees Retirement System of Texas’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-170,400
Closed -$1.7M – 541
2022
Q2
$1.7M Buy
170,400
+32,500
+24% +$322K 0.02% 538
2022
Q1
$1.6M Buy
137,900
+52,500
+61% +$585K 0.02% 600
2021
Q4
$948K Hold
85,400
– – 0.01% 672
2021
Q3
$787K Buy
+85,400
New +$929K 0.01% 717

Other funds holding LFCR

Employees Retirement System of Texas's LFCR Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of Lifecore Biomedical (LFCR) in Q3 2022, closing a stake of 170,400 shares — an estimated $1.7M sold.

Employees Retirement System of Texas first reported a position in LFCR in Q3 2021 and held it in 4 quarters. The position peaked at $1.7M in Q2 2022. 86 funds tracked by Wall St. Rank hold LFCR as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining Lifecore Biomedical position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 170,400 Lifecore Biomedical shares in Q3 2022, an estimated $1.7M.
  • Employees Retirement System of Texas first reported a position in Lifecore Biomedical in Q3 2021 and held it in 4 quarters.
  • Employees Retirement System of Texas's Lifecore Biomedical position peaked at $1.7M in Q2 2022.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.